Literature DB >> 28181362

Risk factors for radiation-induced optic neuropathy: a case-control study.

Ian Ferguson1, Julie Huecker1, Jiayi Huang2, Collin McClelland3, Gregory Van Stavern1.   

Abstract

IMPORTANCE: Identifying risk factors for radiation-induced optic neuropathy (RION) could promote a more conservative approach to radiation treatment planning in vulnerable patients.
BACKGROUND: This study explored possible factors beyond radiation dose associated with the development of RION after external beam radiation therapy.
DESIGN: This was a retrospective case-control study conducted at a university hospital tertiary care center. PARTICIPANTS: Cases (n = 14) meeting criteria for a diagnosis of RION by neuro-ophthalmologic exam were identified from a single-centre neuro-ophthalmology database. Controls (n = 31) without RION were selected from a single-centre radiation oncology database.
METHODS: Controls were matched to cases based upon maximum radiation dose to the optic apparatus. Patient characteristics and treatment parameters were interrogated by univariate analysis for attributes predisposing to RION. MAIN OUTCOME MEASURES: The primary parameter was a significant association of patient characteristics or treatment parameters with RION.
RESULTS: Controlling for radiation dosage, no significant associations for alternative risk factors were identified. CONCLUSIONS AND RELEVANCE: These results support the literature suggesting that the primary risk factor for developing RION is radiation dosage and that additional patient-related and tumour-related risk factors may play only a minor role.
© 2017 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  optic nerve diseases; optic neuropathy; radiation injury

Mesh:

Year:  2017        PMID: 28181362      PMCID: PMC5658779          DOI: 10.1111/ceo.12927

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  25 in total

1.  Visual complications following irradiation for pituitary adenomas and craniopharyngiomas.

Authors:  J R Harris; M B Levene
Journal:  Radiology       Date:  1976-07       Impact factor: 11.105

2.  Outcomes of visual acuity in carbon ion radiotherapy: analysis of dose-volume histograms and prognostic factors.

Authors:  Azusa Hasegawa; Jun-etsu Mizoe; Atsushi Mizota; Hirohiko Tsujii
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-22       Impact factor: 7.038

3.  Risk factors for radiation maculopathy and papillopathy after intraocular irradiation.

Authors:  E S Gragoudas; W Li; A M Lane; J Munzenrider; K M Egan
Journal:  Ophthalmology       Date:  1999-08       Impact factor: 12.079

4.  Neurovisual outcome following proton radiation therapy.

Authors:  I L Habrand; M Austin-Seymour; S Birnbaum; S Wray; R Carroll; J Munzenrider; L Verhey; M Urie; M Goitein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-06       Impact factor: 7.038

5.  Dose-response of critical structures in the posterior eye segment to hypofractioned stereotactic photon radiotherapy of choroidal melanoma.

Authors:  Roman Dunavoelgyi; Dietmar Georg; Martin Zehetmayer; Ursula Schmidt-Erfurth; Richard Pötter; Wolfgang Dörr; Karin Dieckmann
Journal:  Radiother Oncol       Date:  2013-09-14       Impact factor: 6.280

6.  Radiation-induced injury to the visual pathway.

Authors:  G L Jiang; S L Tucker; R Guttenberger; L J Peters; W H Morrison; A S Garden; C S Ha; K K Ang
Journal:  Radiother Oncol       Date:  1994-01       Impact factor: 6.280

7.  Analysis of Vision loss caused by radiation-induced optic neuropathy after particle therapy for head-and-neck and skull-base tumors adjacent to optic nerves.

Authors:  Yusuke Demizu; Masao Murakami; Daisuke Miyawaki; Yasue Niwa; Takashi Akagi; Ryohei Sasaki; Kazuki Terashima; Daisaku Suga; Isao Kamae; Yoshio Hishikawa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-04-03       Impact factor: 7.038

Review 8.  Radiation response of the central nervous system.

Authors:  T E Schultheiss; L E Kun; K K Ang; L C Stephens
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-03-30       Impact factor: 7.038

9.  Unilateral optic neuropathy following vincristine chemotherapy.

Authors:  S W Norton; J A Stockman
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1979 May-Jun       Impact factor: 1.402

10.  Role of total dose and hyperfractionation in reducing risk of radiation-induced optic neuropathy.

Authors:  Dilip Kumre; Vijay Jeswani; Saket Benurwar; Nilesh K Tumram
Journal:  Oman J Ophthalmol       Date:  2015 Jan-Apr
View more
  9 in total

Review 1.  Imaging findings in radiation therapy complications of the central nervous system.

Authors:  Tomonori Kanda; Yuichi Wakabayashi; Feibi Zeng; Yoshiko Ueno; Keitaro Sofue; Takaki Maeda; Munenobu Nogami; Takamichi Murakami
Journal:  Jpn J Radiol       Date:  2018-07-24       Impact factor: 2.374

2.  Predictors of the therapeutic effect of corticosteroids on radiation-induced optic neuropathy following nasopharyngeal carcinoma.

Authors:  Bowen Zheng; Jinpeng Lin; Yi Li; Xiaohuang Zhuo; Xiaolong Huang; Qingyu Shen; Yamie Tang
Journal:  Support Care Cancer       Date:  2019-03-05       Impact factor: 3.603

3.  Peripapillary Neuroendocrine Carcinoma Metastasis: A Novel Approach to Treatment.

Authors:  Colin S Ip; Yuval Raizen; David Goldfarb; Eric Kegley; Jose Munoz; Amy C Schefler
Journal:  Ocul Oncol Pathol       Date:  2021-06-02

4.  Postradiation Optic Atrophy Is Associated With Intraocular Pressure and May Manifest With Neuroretinal Rim Thinning.

Authors:  Lauren A Dalvin; Christopher L Deufel; Kimberly S Corbin; Ivy A Petersen; Timothy W Olsen; Gavin W Roddy
Journal:  J Neuroophthalmol       Date:  2021-11-11       Impact factor: 4.415

5.  Contour Variability in Thyroid Eye Disease with Compressive Optic Neuropathy Treated with Radiation Therapy.

Authors:  Tavish Nanda; Andrew Sanchez; Juhi Purswani; Cheng-Chia Wu; Michael Kazim; Tony J C Wang
Journal:  Adv Radiat Oncol       Date:  2020-02-29

6.  Phase I dose-escalation trial of S-1 combined with carbon-ion radiotherapy for sinonasal squamous cell carcinoma.

Authors:  Daiki Takahashi; Yusuke Demizu; Sung Chul Park; Yoshiro Matsuo; Nor Shazrina Sulaiman; Kazuki Terashima; Sunao Tokumaru; Masaya Akashi; Tomoaki Okimoto
Journal:  J Radiat Res       Date:  2020-09-08       Impact factor: 2.724

7.  Human Umbilical Cord Blood-Derived CD133+CD34+ Cells Protect Retinal Endothelial Cells and Ganglion Cells in X-Irradiated Rats through Angioprotective and Neurotrophic Factors.

Authors:  Siyu Chen; Minghui Li; Jianguo Sun; Dan Wang; Chuanhuang Weng; Yuxiao Zeng; Yijian Li; Shujia Huo; Xiaona Huang; Shiying Li; Ting Zou; Haiwei Xu
Journal:  Front Cell Dev Biol       Date:  2022-02-10

8.  Long-Term Evaluation and Normal Tissue Complication Probability (NTCP) Models for Predicting Radiation-Induced Optic Neuropathy after Intensity-Modulated Radiation Therapy (IMRT) for Nasopharyngeal Carcinoma: A Large Retrospective Study in China.

Authors:  Yan-Ling Wu; Wen-Fei Li; Kai-Bin Yang; Lei Chen; Jing-Rong Shi; Fo-Ping Chen; Xiao-Dan Huang; Li Lin; Xiao-Min Zhang; Jing Li; Yu-Pei Chen; Ling-Long Tang; Yan-Ping Mao; Jun Ma
Journal:  J Oncol       Date:  2022-02-23       Impact factor: 4.375

9.  Loosening Neuro-Optic Structures Dosimetric Constraints Provides High 5-Year Local Recurrence-Free Survival With Acceptable Toxicity in T4 Nasopharyngeal Carcinoma Patients Treated With Intensity-Modulated Radiotherapy.

Authors:  Tingting Zhang; Meng Xu; Jinglin Mi; Hui Yang; Zhengchun Liu; Lulu Huang; Kai Hu; Rensheng Wang
Journal:  Front Oncol       Date:  2021-02-22       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.